RB1 and triple-negative breast carcinoma: Similarly, triple-negative breast cancer cases with disrupted RB pathways tend to exhibit a favorable response to neoadjuvant chemotherapy, gamma radiation, and chemotherapy when compared with tumors with proficient RB (21).